| Gene symbol | CSPG4 | Synonyms | CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2 | Type of gene | protein-coding |
| Chromosome | 15 | Map location | 15q24.2 | dbXrefs | |
| Description | chondroitin sulfate proteoglycan 4 | ||||
| GTO ID | GTC3632 |
| Trial ID | NCT06096038 |
| Disease | Head and Neck Cancer |
| Altered gene | CSPG4 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | iC9.CAR-CSPG4 T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Administration of T Cells Expressing Chondroitin-Sulfate-Proteoglycan-4 Specific Chimeric Antigen Receptors (CAR) in Subjects With Head and Neck Squamous Cell Carcinoma (HNSCC) |
| Year | 2024 |
| Country | United States |
| Company sponsor | UNC Lineberger Comprehensive Cancer Center |
| Other ID(s) | LCCC2060-ATL |
| Cohort 1 | |||||||||||
|
|||||||||||